Research Type: Extramural
If the project is successful, it would be one of the first targeted treatments for triple-negative breast cancer, with potential for improved survival rates.
This project aims to find out how certain immune cells could be controlled and how they might be used to predict who will respond to immunotherapy.
The aim of this project is to discover which melanoma patients will benefit the most from the use of BET inhibitor drug treatment.
If successful, this study should significantly improve the patient care of those suffering with advanced liver cancer by making drug treatment more effective.
This project aims to reduce the duration, cost and complications of fungal infections, with a significant reduction in cancer patients suffering.
This project is focused on overcoming the problem of relapse of melanoma in patients being treated by immunotherapy with checkpoint inhibitors.
The project will aim to develop online training interventions to improve communication, support and engagement with family carers, to help them feel empowered in their caregiving role.
This project aims to discover how a particular protein called BRD4 leads to the development and growth of tumours in children with TERT-rearranged neuroblastoma.
This project aims to develop a tailored treatment approach for pancreatic cancer, providing more effective options and boosting the chances of a good outcome.
This project will lead to a clinical trial of a developed test to ensure the right patients receive and benefit from focal therapy for prostate cancer.